Sunday, January 25, 2015 6:38:02 PM
We have been told for years that the delays and hurdles are all due to the novel and new platform that hasn't been accepted by TPTB.
If ebolcide2 fails, there is no going back and saying "well, sure, our platform failed to kill Ebola, but never fear, it will work on the Flu virus"
And ebolacide has a much bigger spotlight on it right now. So all those evil pharmaceutical companies that have been conspiring to keep NNVC down (another familiar BS excuse as to why this dog can't get past Tox) will make a lot noise about this failure.
The reality is that going after ebola was a huge distraction, diverted time and material from Flucide Tox. The company stated this would not be the case, but it was. The company stated they didn't need the new facility to produce material for Tox, but that was also not true.
The list of lies and deceptive statements from this company is significantly longer than any legitimate and fulfilled statements...of which there have been NONE.
Tox CAN NOT be completed in '15. Plain and simple.
The SwingTrade Portfolio was up 36.2% in 2014, 83.5% in 2013, and 510.9% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=109534893
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM